Developer docs
API playgroundTry for free, no card

Search company profiles

MI Bioresearch

Full company profile

uuid000sihv

Namestring
MI Bioresearch
Company typeenum
Private
Founded yearint
2003
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAnn Arbor, United States
HQ citystring
Ann Arbor
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
preclinical imaging services, contract research organization, in vivo imaging, preclinical CRO, oncology imaging
Industry1 code
PRIMARYHLAGAFAC
DMPK / ADME & Bioanalysis
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Preclinical Contract Research Services
Social media profiles1 record
Cost components4 values
Personnel, Operations, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

MI Bioresearch is a contract research organization providing in vivo preclinical imaging services for drug development and translational research, with emphasis on oncology. The company delivers imaging-based preclinical study support to biopharmaceutical and academic research sponsors using animal models.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1In Vivo Preclinical Imaging Services
CategoryPreclinical Contract Research Services
No data
Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MI Bioresearch

Preclinical Contract Research Servicesmolecularimaging.com

MI Bioresearch firmographics

Firmographics
Name
MI Bioresearch
Website
https://molecularimaging.com
Company type
Private
Founded year
2003
Headcount range
11–50 employees
Ownership category
akta.pro rank

MI Bioresearch industry classification

Industry
Product category
Preclinical Contract Research Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAFAC
DMPK / ADME & Bioanalysis
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)

Keywords

  • Preclinical imaging services
  • Contract research organization
  • In vivo imaging
  • Preclinical CRO
  • Oncology imaging

Where MI Bioresearch is headquartered

Location

Headquarters

HQ city
Ann Arbor
HQ country
United States
HQ region
North America

Markets served

MI Bioresearch business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure

MI Bioresearch product offering

Product offering

Core offering

MI Bioresearch is a contract research organization providing in vivo preclinical imaging services for drug development and translational research, with emphasis on oncology. The company delivers imaging-based preclinical study support to biopharmaceutical and academic research sponsors using animal models.

Differentiator

Problem solved

Functional benefit

Products and services

  • In Vivo Preclinical Imaging Services

Companies that use MI Bioresearch

Customer profile

Ideal customer profiles1 record

MI Bioresearch technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

MI Bioresearch competitors and assessment

Company assessment

Market position

Customer concentration

MI Bioresearch social profiles

Digital presence

MI Bioresearch financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MI Bioresearch leadership team

Management profile

Number of profiles

Profiles3 records

MI Bioresearch funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MI Bioresearch M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MI Bioresearch

What does MI Bioresearch do?

MI Bioresearch is a contract research organization providing in vivo preclinical imaging services for drug development and translational research, with emphasis on oncology. The company delivers imaging-based preclinical study support to biopharmaceutical and academic research sponsors using animal models.

When was MI Bioresearch founded?

MI Bioresearch was founded in 2003. It employs 11 to 50 people.

Where is MI Bioresearch based?

MI Bioresearch is headquartered in Ann Arbor, United States, in the North America region.

Does MI Bioresearch have an API?

No public API is recorded for MI Bioresearch.

What industry is MI Bioresearch in?

MI Bioresearch's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAFAC, DMPK / ADME & Bioanalysis. Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewswireFlow Cytometry-Based Tools to Enrich Your Preclinical Immuno-Oncology Research, New Webinar Hosted by XtalksMI Bioresearch will host a webinar on May 16, 2018, to present flow cytometry-based tools for preclinical immuno-oncology research. The presentation covers ex vivo immunophenotypic analysis, cytokine responses, and signaling pathways, aiming to help interpret drug mechanisms.PrwebRBMA and Associated Sciences Consortium Sponsor Additional Educational Offerings at RSNARBMA and the Associated Sciences Consortium will sponsor eight 90-minute courses at the RSNA annual meeting in Chicago, one more than last year. Topics include global health challenges, MR safety, and radiation dose optimization. Early online registration ends Nov. 4.PrwebLoma Linda University and Siemens’ PETNET Solutions, Inc. Announce Operational State-of-the-Art PET Production and Research Facility to Advance Molecular ImagingLoma Linda University and Siemens' PETNET Solutions completed a PET production and research facility on the university's campus, featuring two cyclotrons and a radiochemistry lab. The center will support pre-clinical and clinical trials, with equipment for purification installed this month to enable human subject trials. Siemens' PETNET Solutions will supply clinical doses of radiopharmaceuticals.PR NewswireGlobal Cytogenetics Report 2015 - Updated Technologies, Markets and Companies Market Analysis with Forecasts to 2019 & 2024Research and Markets published a report on cytogenetics covering technologies, markets, and companies, with market figures for 2014 and estimates for 2019 and 2024. FISH is highlighted as the most advanced technology, while single-molecule detection is noted as having more future potential. The report profiles 69 companies and 79 collaborations.PR NewswireGlobal Cytogenetics Report 2015 - Updated Technologies, Markets and Companies Market Analysis with Forecasts to 2019 & 2024Research and Markets published a report on cytogenetics covering technologies, markets, and companies, with market estimates for 2019 and 2024. FISH is highlighted as the most advanced technology, while single-molecule detection is noted as having more future potential. The report profiles 69 companies and 79 collaborations.PR NewswireGlobal Cytogenetics Market Report 2015-2024 - Technologies, Markets and CompaniesResearch and Markets published a report on cytogenetics technologies, markets, and companies, covering FISH, microarrays, and nanobiotechnology. It profiles 69 companies and 79 collaborations, with 27 tables, 9 figures, and 200 references.